Gene Query: ANXA4

Dataset Description Geneva Score
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 77.54
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 77.54
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 55.12
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 55.12
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 49.27
Pharmacologic inhibition of STAT5 in AML 46.13
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 45.62
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 42.52
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 41.43
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 40.21
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 40.21
Global expression profiles in cardiac progenitor cells generated by ISX-9 40.21
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 39.08
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 38.18
Transcriptome analysis of kidney organoids 35.98
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 35.58
Nrf2 regulated genes in A549 cells 35.0
Identification of Nrf2 regulated genes by RNA sequencing 35.0
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 34.74
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 34.45
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 34.05
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 32.17
RNA-seq analysis of AML cells in response to ASLAN003 31.63
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 30.66
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 29.92
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 29.87
RNA-seq of YB5 cells treated with Proscillaridin A 29.28
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 29.16
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 27.86
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 27.86
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 27.4
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 27.38
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 27.38
Primary human trophoblast from term placenta 27.19
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 26.27
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 26.27
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 25.4
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 25.37
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 24.95
Identification of Sin3B regulated genes during quiescence 24.53
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 24.35
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 24.32
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 24.23
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 24.13
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 23.99
BAF controls genome accessibility 23.64
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 23.63
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 23.54
METTL3 promotes translation in human cancer cells 23.39
Genome-wide transcriptional response to random aneuploidy in human cells 23.18
High-Throughput Kinetic Analysis of Fractional Killing 23.09
ZIKV infection of monocytes activates inflammasome pathways 22.79
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 22.73
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 22.66
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 22.36
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 22.29
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 21.95
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 21.54
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 21.36
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 21.15
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 20.95
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 20.66
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 20.09
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 19.77
Expression by CD133+ cells isolated from the adult human exocrine pancreas 19.66
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 19.53
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 19.34
MOF acetyl transferase regulates transcription and respiration in mitochondria 19.1
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 19.07
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 18.83
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 18.83
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 18.66
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 18.59
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 18.59
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 18.51
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 18.51
Changes in human endometrial gland transcriptome over the window of implantation 18.42
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 18.27
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 18.27
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 18.18
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 18.07
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 17.99
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 17.9
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 17.56
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 17.56
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 17.15
Gene expression analysis of the impact of TDP-43 knockout in human cells. 16.9
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 16.86
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 16.7
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 16.61
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 16.56
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 16.47
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 16.13
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 16.13
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 16.02
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 15.93
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 15.76
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 15.75
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 15.75
NHLRC1 re-expression in cancer cells 15.59
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 15.56
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 15.53
Cell responses to dysregulated VZV-induced cell-cell fusion 15.52
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 15.51
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 15.49
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 15.46
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 15.37
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 15.29
Crizotinib v. DMSO in SW480 cells 15.28
A sister of NANOG regulates genes expressed in pre-implantation human development 15.22
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 15.19
The landscape of alternative splicing in aggressive prostate cancers 15.11
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 15.11
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 14.93
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 14.92
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 14.92
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 14.88
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 14.88
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 14.84
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 14.84
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 14.55
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 14.5
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 14.41
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 14.41
Gene Expression Profiling of SPOP Knocked Down Cell 14.4
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 14.39
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 14.26
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 14.21
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 14.17
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 14.17
ARS2 is a general suppressor of pervasive transcription [RNAseq] 14.16
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 14.16
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 14.07
Knockdown of ADNP in HCT116 colon cancer cells 14.04
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 13.98
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 13.87
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 13.85
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 13.5
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 13.27
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 13.24
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 13.24
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 13.13
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 13.12
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 13.04
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 13.01
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 13.01
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 12.73
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 12.71
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 12.52
Postnatal lipids drive hepatocyte maturation 12.46
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 12.45
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 12.4
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 12.33
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 12.31
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 12.31
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 12.31
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 12.23
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 12.17
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 12.16
RNA-seq of young and quiescent MRC-5 human fibroblasts 12.08
Toxoplasma gondii infection of human retinal pigment epithelial cells 11.95
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 11.87
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 11.84
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 11.79
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 11.38
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 11.38
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 11.33
The regulartory role of ZCCHC24 in splicing machinery 11.2
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 11.07
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 11.07
RNA-seq analysis to identify the genes regulated by p53-SET interplay 10.95
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 10.94
Proliferation-correlated expression 10.93
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 10.91
Gene expression signatures of innate lymphoid cells from human blood 10.91
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 10.83
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 10.8
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 10.74
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 10.66
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 10.59
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 10.59
mRNA-Seq profiling of human developing kidney 10.53
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 10.51
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 10.46
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 10.46
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 10.38
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 10.38
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 10.25
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 10.15
Direct Isolation and Characterization of Human Nephron Progenitors. 10.11
RNA-seq analysis of uveal melanoma cells treated with FR900359 10.06
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 10.01
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 10.01
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 9.91
High-efficiency RNA-based reprogramming of human primary fibroblasts 9.88
Hypoxic transcriptome of SQ20B human head and neck cancer cells 9.88
Gene expression analysis of dengue-infected cells 9.86
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 9.84
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 9.83
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 9.79
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 9.78
Differential analysis of gene regulation at transcript resolution by RNA-Seq 9.78
Generation and functional characterization of MDSC-like cells 9.77
Expression level comparison under dividing and quiescent states in human primary fibroblasts 9.76
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 9.74
MARCKS and lnc-MARCKS act as inflammation regulators 9.74
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 9.73
Total RNA sequencing of APC mutant and wt colonic organoids 9.72
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 9.69
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 9.68
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 9.55
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 9.48
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 9.44
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 9.35
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 9.34
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 9.31
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 9.28
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 9.27
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 9.27
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 9.21
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 9.2
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 9.2
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 9.15
Effect of from Human Umbilical Vein Endothelial Cells 9.1
Impact on erythroid progenitor type on erythroid differntiation 9.08
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 9.08
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 9.06
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 9.06
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 9.06
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 9.06
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 8.96
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 8.96
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 8.91
Transcriptome wide analysis of classically and alternatively activated macrophages 8.88
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 8.87
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 8.78
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 8.78
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 8.78
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 8.74
The pioneer factor CEBPA modulates vitamin D signaling 8.68
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 8.68
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 8.6
Expression profiling of MCF-7 cells with treatment of TCDD 8.6
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 8.58
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 8.56
RNA-seq analysis of the human fetal kidney. 8.55
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 8.55
Neurofibroma 8.55
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 8.54
An RNA-centric dissection of host complexes controlling flavivirus infection 8.54
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 8.54
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 8.52
HNF1 regulates critical functions of the human epididymis epithelium. 8.52
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 8.45
Ebola virus (EBOV) infection of ARPE-19 cells 8.44
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 8.43
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 8.43
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  8.42
Statins modulate endothelial transcriptional profile by inhibiting EZH2 8.35
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 8.29
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 8.27
Effect of Influenza virus infection on lncRNA expression in A549 cells 8.22
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 8.18
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 8.17
Differential gene expression profiles in imatinib-resistant cell lines 8.13
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 8.06
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 8.06
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 8.06
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 8.04
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 7.99
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 7.98
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 7.87
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 7.85
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 7.82
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 7.8
RNA-sequencing 7.75
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 7.75
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 7.73
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.69
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 7.68
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 7.68
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 7.62
Searching for target genes of miR-508/509/506/514 in HCT116 cells 7.61
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 7.52
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 7.51
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 7.49
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.48
Silencing SPIB in attached and floating state of H1703 lung cancer cells 7.43
Epigenome regulation during epidermal lineage commitment 7.42
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 7.38
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 7.37
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 7.36
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 7.36
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 7.34
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 7.3
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 7.25
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 7.2
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 7.2
PGE2 mediated gene expression changes in human cervical stromal cells 7.16
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 7.11
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 7.07
Next Generation Sequencing of human SMA and healthy control Motor Neurons 7.03
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 7.0
RNA-seq of SCLC PDX models treated with EP 6.96
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 6.95
Human Treg NaCl stimulation 6.9
Efficient derivation of microglia-like cells from human pluripotent stem cells 6.89
Single-cell analysis of human kidney organoids 6.85
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 6.84
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 6.68
X-Ray induced DNA-Hydroxymethylation changes 6.64
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 6.63
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 6.63
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 6.6
The Genetic Landscape of Diamond-Blackfan Anemia 6.59
Transcriptome profiling of A2M treated A549 Cell Line Samples 6.57
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 6.56
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 6.5
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 6.4
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 6.34
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 6.27
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 6.27
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.22
p63 controls the enhancer landscape during keratinocyte differentiation 6.19
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 6.17
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 6.12
Clinker: visualizing fusion genes detected in RNA-seq data 6.07
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 5.98
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 5.96
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 5.96
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 5.96
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 5.94
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 5.79
Persistence of stem cell metabolism in cancers as a failure of differentiation 5.78
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 5.77
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 5.76
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 5.71
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 5.71
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 5.71
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 5.7
Genome-wide identification of cancer-specific alternative splicing in circRNA 5.68
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 5.65
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.61
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 5.59
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 5.59
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 5.59
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 5.5
Androgen Receptor-regulated genes in prostate cancer cells 5.47
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 5.47
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 5.42
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 5.42
Gene expression profile of human placenta from T. Cruzi infected mothers 5.35
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 5.29
Transcriptional landscape changes during human embryonic stem cell derivation 5.24
Transciptomic profiling of human fetal lung samples 5.23
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 5.18
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 5.09
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 5.02
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 4.91
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 4.91
Random mono-allelic expression in MECP2-mutated cells 4.9
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 4.87
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 4.87
Identifying the molecular mode of action of itraconazole in colorectal cancer 4.82
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 4.78
Transcriptome profiling of 5 human adenocarcinoma cell lines 4.74
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 4.69
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 4.66
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 4.65
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 4.54
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.45
Transcriptional profile in human S. haematobium infection 4.41
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 4.33
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.32
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 4.29
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 4.26
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 4.25
Loss of endometrial plasticity in recurrent pregnancy loss 4.16
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 4.16
CSL RNA-Seq on HKC and SCC cell lines 4.1
CSL 4.1
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 3.95
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 3.89
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 3.87
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 3.87
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 3.85
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 3.84
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 3.78
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 3.78
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 3.68
MAIT cell RNA sequencing 3.63
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 3.62
A single-cell transcriptome atlas of the human pancreas 3.6
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 3.58
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 3.48
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 3.47
Transcriptome of EBV-infected gastric cancer cell lines 3.47
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 3.44
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 3.44
Gene profiling of human adult and pediatric liver cancer cells 3.44
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 3.4
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 3.32
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 3.32
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 3.3
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 3.3
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 3.15
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 3.03
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.87
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 2.84
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 2.83
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 2.82
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 2.82
Human islets of varying quality: the good, the (not so) bad and the ugly 2.79
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 2.72
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 2.62
In situ CAPTURE of chromatin interactions by biotinylated dCas9 2.62
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 2.62
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 2.58
RNA sequencing of human pancreatic cancer cell lines 2.58
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 2.57
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 2.56
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 2.55
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 2.47
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 2.44
Common inflammatory pathways between NEC and Crohn's disease 2.44
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 2.42
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 2.41
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 2.4
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.23
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 2.22
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 2.2
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 2.2
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 2.15
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 2.14
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 2.1
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 2.08
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 2.06
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.92
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 1.91
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 1.88
Transcriptome analyses of human pancreatic islets and pseudoislets 1.86
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 1.86
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 1.82
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 1.8
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 1.66
6mer seed toxicity in tumour suppressive microRNAs 1.55
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.53
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.51
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.47
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.43
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 1.41
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 1.41
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 1.33
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.31
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.27
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.24
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 1.24
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.18
Identification of long noncoding RNAs regulated by p53 1.17
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.14
MHC Transcriptomic landscape at haplotype-specific resolution 1.06
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.04
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.03
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 1.03
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 1.0
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 1.0
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.97
Identification of expressed and conserved human non-coding RNAs 0.97
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  0.83
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 0.82
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.8
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.8
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.7
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 0.66
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.64
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.62
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.6
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.59
Finding missing proteins from epigenetically manipulated human cells 0.57
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.55
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.53
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 0.51
The expression profiles of GBC liver metastasis 0.5
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.46
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.46
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.45
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.38
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.38
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.37
Engineering Patient-Specific Tissue Implants 0.37
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.35
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.25
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.23
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.23
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 0.22
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.18
6mer seed toxicity in viral microRNAs 0.08
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.07
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.02
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation